Cargando…
Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration
BACKGROUND: The success of developing cardiovascular tissue engineering (CTE) grafts greatly needs a readily available cell substitute for endothelial and interstitial cells. Perinatal annexes have been proposed as a valuable source of mesenchymal stem cells (MSCs) for tissue engineering and regener...
Autores principales: | Pu, Lei, Meng, Mingyao, Wu, Jian, Zhang, Jing, Hou, Zongliu, Gao, Hui, Xu, Hui, Liu, Boyu, Tang, Weiwei, Jiang, Lihong, Li, Yaxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359832/ https://www.ncbi.nlm.nih.gov/pubmed/28320452 http://dx.doi.org/10.1186/s13287-017-0501-x |
Ejemplares similares
-
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011) -
Combining Mesenchymal
Stem Cells Derived from Wharton’s
Jelly and Amniotic Biomaterial Scaffolds for Cell Delivery
por: Palaniappan, Umamagesh, et al.
Publicado: (2023) -
Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014) -
Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)